-transparent.png){kind=logo}
We studied 15 hyperprolactinemic women to evaluate possible modifications of bone mineral content after pharmacological treatment. Patients received a dopamine agonist (bromocriptine) for six months after which there was a significant decrease of prolactin plasma levels (P less than 0.01) and a significant increase of bone mineral content (P less than 0.05).
Related Publications
M P Caraceni, and
E Corghi, and
S Ortolani, and
S Casazza, and
A D'Alberton, and
T Motta
August 1989,
BMJ (Clinical research ed.),
M P Caraceni, and
E Corghi, and
S Ortolani, and
S Casazza, and
A D'Alberton, and
T Motta
November 1981,
Acta paediatrica Scandinavica,
M P Caraceni, and
E Corghi, and
S Ortolani, and
S Casazza, and
A D'Alberton, and
T Motta
July 1985,
Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
M P Caraceni, and
E Corghi, and
S Ortolani, and
S Casazza, and
A D'Alberton, and
T Motta
February 1977,
Calcified tissue research,
M P Caraceni, and
E Corghi, and
S Ortolani, and
S Casazza, and
A D'Alberton, and
T Motta
January 1988,
Yonsei medical journal,
M P Caraceni, and
E Corghi, and
S Ortolani, and
S Casazza, and
A D'Alberton, and
T Motta
January 2010,
The journal of physiological sciences : JPS,
M P Caraceni, and
E Corghi, and
S Ortolani, and
S Casazza, and
A D'Alberton, and
T Motta
January 1986,
Annali di ostetricia, ginecologia, medicina perinatale,
M P Caraceni, and
E Corghi, and
S Ortolani, and
S Casazza, and
A D'Alberton, and
T Motta
March 1985,
Arhiv za higijenu rada i toksikologiju,
M P Caraceni, and
E Corghi, and
S Ortolani, and
S Casazza, and
A D'Alberton, and
T Motta
October 1991,
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
M P Caraceni, and
E Corghi, and
S Ortolani, and
S Casazza, and
A D'Alberton, and
T Motta
September 1984,
The New England journal of medicine,
